Benjamin A Vervaet

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Placebo Controlled

Epithelial Mesenchymal Transition

Cardiovascular Disease

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Raphaëlle Corremans, Benjamin A Vervaet, Geert Dams, Patrick C D'Haese, Anja Verhulst
Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect. International journal of molecular sciences 24 (10) (2023)
Raphaëlle Corremans, Patrick C D'Haese, Benjamin A Vervaet, Anja Verhulst
L-NAME Administration Enhances Diabetic Kidney Disease Development in an STZ/NAD Rat Model. International journal of molecular sciences 22 (23) (2021)
Lies Moonen, Hilde Geryl, Patrick C D'Haese, Benjamin A Vervaet
Short-term dexamethasone treatment transiently, but not permanently, attenuates fibrosis after acute-to-chronic kidney injury. BMC nephrology 19 (1) (2018)
Raphaëlle Corremans, Benjamin A Vervaet, Patrick C D'Haese, Ellen Neven, Anja Verhulst
Metformin: A Candidate Drug for Renal Diseases. International journal of molecular sciences 20 (1) (2018)